554 related articles for article (PubMed ID: 33488588)
1. Epstein-Barr Virus and Systemic Autoimmune Diseases.
Houen G; Trier NH
Front Immunol; 2020; 11():587380. PubMed ID: 33488588
[TBL] [Abstract][Full Text] [Related]
2. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
3. How compelling are the data for Epstein-Barr virus being a trigger for systemic lupus and other autoimmune diseases?
Draborg A; Izarzugaza JM; Houen G
Curr Opin Rheumatol; 2016 Jul; 28(4):398-404. PubMed ID: 26986247
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus in autoimmune diseases.
Toussirot E; Roudier J
Best Pract Res Clin Rheumatol; 2008 Oct; 22(5):883-96. PubMed ID: 19028369
[TBL] [Abstract][Full Text] [Related]
5. Epstein Barr Virus and Autoimmune Responses in Systemic Lupus Erythematosus.
Jog NR; James JA
Front Immunol; 2020; 11():623944. PubMed ID: 33613559
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus in systemic autoimmune diseases.
Draborg AH; Duus K; Houen G
Clin Dev Immunol; 2013; 2013():535738. PubMed ID: 24062777
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr Virus Lytic Reactivation Induces IgG4 Production by Host B Lymphocytes in Graves' Disease Patients and Controls: A Subset of Graves' Disease Is an IgG4-Related Disease-Like Condition.
Nagata K; Hara S; Nakayama Y; Higaki K; Sugihara H; Kuwamoto S; Matsushita M; Kato M; Tanio S; Ishiguro K; Hayashi K
Viral Immunol; 2018 Oct; 31(8):540-547. PubMed ID: 30222515
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of the Epstein-Barr Virus in Autoimmune Inflammatory Rheumatic Diseases in Northern Brazil.
França SAS; Viana JBGO; Góes HCA; Fonseca RRS; Laurentino RV; Costa IB; Oliveira-Filho AB; Machado LFA
Viruses; 2022 Mar; 14(4):. PubMed ID: 35458425
[TBL] [Abstract][Full Text] [Related]
9. Increased antibody levels to stage-specific Epstein-Barr virus antigens in systemic autoimmune diseases reveal a common pathology.
Sternbæk L; Draborg AH; Østerlund MT; Iversen LV; Troelsen L; Theander E; Nielsen CT; Jacobsen S; Houen G
Scand J Clin Lab Invest; 2019; 79(1-2):7-16. PubMed ID: 30727744
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus and multiple sclerosis.
Pohl D
J Neurol Sci; 2009 Nov; 286(1-2):62-4. PubMed ID: 19361810
[TBL] [Abstract][Full Text] [Related]
11. Discrepancy of Serological and Molecular Patterns of Circulating Epstein-Barr Virus Reactivation in Primary Sjögren's Syndrome.
Sanosyan A; Daien C; Nutz A; Bollore K; Bedin AS; Morel J; Zimmermann V; Nocturne G; Peries M; Guigue N; Gottenberg JE; Van de Perre P; Mariette X; Tuaillon E
Front Immunol; 2019; 10():1153. PubMed ID: 31191532
[TBL] [Abstract][Full Text] [Related]
12. A possible link between the Epstein-Barr virus infection and autoimmune thyroid disorders.
Dittfeld A; Gwizdek K; Michalski M; Wojnicz R
Cent Eur J Immunol; 2016; 41(3):297-301. PubMed ID: 27833448
[TBL] [Abstract][Full Text] [Related]
13. The role of Epstein-Barr virus infection in primary Sjögren's syndrome.
Maślińska M
Curr Opin Rheumatol; 2019 Sep; 31(5):475-483. PubMed ID: 31356378
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus and cytomegalovirus in autoimmune diseases: are they truly notorious? A preliminary report.
Barzilai O; Sherer Y; Ram M; Izhaky D; Anaya JM; Shoenfeld Y
Ann N Y Acad Sci; 2007 Jun; 1108():567-77. PubMed ID: 17894021
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism.
Serafini B; Rosicarelli B; Veroni C; Mazzola GA; Aloisi F
J Virol; 2019 Dec; 93(24):. PubMed ID: 31578295
[TBL] [Abstract][Full Text] [Related]
16. [Investigation of Epstein-Barr virus and herpes simplex virus markers by serological and molecular methods in patients with rheumatoid arthritis and systemic lupus erythematosus].
Us T; Cetin E; Kaşifoğlu N; Kaşifoğlu T; Akgün Y
Mikrobiyol Bul; 2011 Oct; 45(4):677-83. PubMed ID: 22090298
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Epstein-Barr Virus infection in immunocompromised patients.
Pociupany M; Snoeck R; Dierickx D; Andrei G
Biochem Pharmacol; 2024 Jul; 225():116270. PubMed ID: 38734316
[TBL] [Abstract][Full Text] [Related]
18. Persistence of Epstein-Barr virus in self-reactive memory B cells.
Tracy SI; Kakalacheva K; Lünemann JD; Luzuriaga K; Middeldorp J; Thorley-Lawson DA
J Virol; 2012 Nov; 86(22):12330-40. PubMed ID: 22951828
[TBL] [Abstract][Full Text] [Related]
19. [Epstein-Barr virus infection - life cycle, methods of diagnosis, associated diseases].
Bocian J; Januszkiewicz-Lewandowska D
Postepy Hig Med Dosw (Online); 2011 May; 65():286-98. PubMed ID: 21677354
[TBL] [Abstract][Full Text] [Related]
20. Association between EBV serological patterns and lymphocytic profile of SjS patients support a virally triggered autoimmune epithelitis.
Barcelos F; Martins C; Monteiro R; Cardigos J; Prussiani T; Sítima M; Alves N; Vaz-Patto J; Cunha-Branco J; Borrego LM
Sci Rep; 2021 Feb; 11(1):4082. PubMed ID: 33603079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
